Home › BECTON, DICKINSON AND COMPANY › BD BBL™ CHROMAgar™ Orient/TSA II W/5% SB
BD BBL™ CHROMAgar™ Orient/TSA II W/5% SB
BECTON, DICKINSON AND COMPANY · Model 222239 · UDI-DI 10382902222399
JSH
Prescription
10
510(k) clearances
173
Adverse events
2
Recalls
29
Facilities
Description
BD BBL™ CHROMagar™ Orientation and BD BBL™ Trypticase™ Soy Agar with 5% Sheep Blood (TSA II)– BD I Plate™, Carton of 100 plates
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-07-11 | Remel, Inc | The products may contain surface and subsurface contamination of Listeria monocytogenes. |
| 2017-03-24 | Remel Inc | Confirmed complaint of surface contamination of Listeria monocytogenes. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.